RecruitingNCT04755764

Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy

The Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by Impedance Cardiography in Early Pregnancy

Sponsor

Marshall University

Enrollment

60 participants

Start Date

Mar 3, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of the research is to characterize the effect of labetalol, atenolol, and nifedipine on maternal hemodynamics early in pregnancy. Patients will be given medication based on their hemodynamics and asked to return for a repeat measurement.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Inclusion Criteria5

Patients presenting to Maternal Hypertension Center at Cabell Huntington Hospital
English speaking
years old.
Willing to provide informed consent
Gestational age prior to 15 weeks gestation

Exclusion Criteria4

Non-English speaking patients, patients
\<18 years old or \>45 years old
Not willing or able to provide consent
Gestational age \>15 weeks

Interventions

DRUGLabetalol

Beta blocker

DRUGAtenolol

Beta blocker

DRUGNifedipine

Calcium channel blocker

Locations(1)

Maternal Hypertension Center at Cabell Huntington Hospital

Huntington, West Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04755764

Related Trials

Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States

NCT0729355911 locations